World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Boardroom Cuts Won't Cure AstraZeneca
Keywords:
With no clear strategy to pursue vaccines or generics like its competitors, and no promising new drugs in the pipeline, Astra Zeneca faces an uncertain future. Acquisitions are costly with a high premium in 2012. Nestle paid about 20 times earnings before interest, depreciation and taxes for Pfizer's baby food nutrition business. Astra Zeneca's first quarter earnings in 2012 declined by 44%. Government price reductions and competition from generics led to first quarter 2012 sales decline by 11%. New management takes over in June from the current CEO.
AstraZeneca
01/12/2007
Grouped Articles
Astra Isn't Immune to Competition
Wall Street Journal 03/22/2014
AstraZeneca’s Shaky Bridge to Pipeline’s Promise
Wall Street Journal 11/18/2014
AstraZeneca, Bristol-Myers To Team Up on 2 Drugs
Wall Street Journal 01/12/2007
Wall Street Journal 05/22/2007
AstraZeneca Wins Legal Halt Of Rival Drug
Wall Street Journal 11/21/2008
AstraZeneca, Teva Set Accord on Asthma Drug
Wall Street Journal 11/25/2008
AstraZeneca performance
02/27/2009
Grouped Articles
Astra Zeneca in Deal to Buy Pearl Therapeutics worth $1.5 Billion
New York Times 06/10/2013
For $520 Million, AstraZeneca Will Settle Case Over Marketing of a Drug
New York Times 04/26/2010
Astra Isn't Immune to Competition
Wall Street Journal 03/22/2014
Pfizer to Pursue Bid for AstraZeneca
Wall Street Journal 04/28/2014
U.S. DOJ Closes Probe Into AstraZeneca's Heart Drug Brilinta
Wall Street Journal 08/20/2014
AstraZeneca’s Shaky Bridge to Pipeline’s Promise
Wall Street Journal 11/18/2014
AstraZeneca strategies
02/27/2009
Grouped Articles
Astra Zeneca in Deal to Buy Pearl Therapeutics worth $1.5 Billion
New York Times 06/10/2013
AstraZeneca Cozies Up to Cambridge University
Wall Street Journal 10/25/2013
Astra Isn't Immune to Competition
Wall Street Journal 03/22/2014
Pfizer to Pursue Bid for AstraZeneca
Wall Street Journal 04/28/2014
AstraZeneca’s Shaky Bridge to Pipeline’s Promise
Wall Street Journal 11/18/2014
AstraZeneca Deals Up a Tricky 2015
Wall Street Journal 02/06/2015
AstraZeneca management
02/27/2009
Grouped Articles
Astra Isn't Immune to Competition
Wall Street Journal 03/22/2014
Pfizer to Pursue Bid for AstraZeneca
Wall Street Journal 04/28/2014
AstraZeneca’s Shaky Bridge to Pipeline’s Promise
Wall Street Journal 11/18/2014
AstraZeneca Deals Up a Tricky 2015
Wall Street Journal 02/06/2015
AstraZeneca to Buy Actavis’s Respiratory Drug Business in U.S., Canada
Wall Street Journal 02/06/2015
AstraZeneca Needs to Set Itself Free
Wall Street Journal 01/04/2016
AstraZeneca legal settlements
02/27/2009
Grouped Articles
For $520 Million, AstraZeneca Will Settle Case Over Marketing of a Drug
New York Times 04/26/2010
U.S. DOJ Closes Probe Into AstraZeneca's Heart Drug Brilinta
Wall Street Journal 08/20/2014
AstraZeneca to Gain From Tax Deal
Wall Street Journal 03/28/2011
AstraZeneca Settles Most Seroquel Suits
New York Times 07/29/2011
Astra Cuts Sales Force in U.S. 24%
Wall Street Journal 12/08/2011
AstraZeneca Plans to Cut 7,300 Jobs
Wall Street Journal 02/03/2012
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us
